Hepatitis C virus infection in Samoa and American Samoa.
Little is known about the prevalence of hepatitis C virus (HCV) in Pacific islands. In this study, serum specimens collected in 1985 and 2002 among the general populations of Samoa and American Samoa were tested for antibody to HCV by a third-generation enzyme immunoassay and a recombinant immunoblot assay. Of the 3,466 specimens tested, 8 (0.2%; 95% confidence interval = 0.07-0.4%) were positive for antibody to HCV. Prevalence did not vary by location or demographic characteristic. Thus, HCV is present in the Samoas but at a low prevalence.
Armstrong
Gregory L
GL
Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. garmstrong@cdc.gov
Williams
Ian T
IT
Maga
Utoofili Asofa'Afetai
UA
Viali
Satupaitea
S
Kuhnert
Wendi L
WL
McGarvey
Stephen T
ST
D018948:American Samoa / Q000453:epidemiology; D004797:Enzyme-Linked Immunosorbent Assay; D016174:Hepacivirus / Q000276:immunology / Q000302:isolation & purification; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D015151:Immunoblotting; D015995:Prevalence; D018947:Samoa / Q000453:epidemiology